[go: up one dir, main page]

HK1230969A1 - Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same - Google Patents

Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same Download PDF

Info

Publication number
HK1230969A1
HK1230969A1 HK17104764.7A HK17104764A HK1230969A1 HK 1230969 A1 HK1230969 A1 HK 1230969A1 HK 17104764 A HK17104764 A HK 17104764A HK 1230969 A1 HK1230969 A1 HK 1230969A1
Authority
HK
Hong Kong
Prior art keywords
hepe
methods
same
pharmaceutical compositions
treating asthma
Prior art date
Application number
HK17104764.7A
Other languages
Chinese (zh)
Inventor
Mehar Manku
John Climax
Kevin Duffy
Original Assignee
Afimmune Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afimmune Limited filed Critical Afimmune Limited
Publication of HK1230969A1 publication Critical patent/HK1230969A1/en

Links

Abstract

The disclosure provides compositions comprising 15-HEPE or derivatives thereof used singly or in combination with other active agents for the treatment and/or prevention of lung diseases and disorders such as asthma.
HK17104764.7A 2014-01-10 2015-01-12 Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same HK1230969A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/926,052 2014-01-10

Publications (1)

Publication Number Publication Date
HK1230969A1 true HK1230969A1 (en) 2017-12-15

Family

ID=

Similar Documents

Publication Publication Date Title
WO2015077503A8 (en) Autotaxin inhibitor compounds
CA2956871C (en) Compounds active towards bromodomains
WO2015106215A3 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
PH12017501611A1 (en) Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
MX2016012262A (en) Cenicriviroc for the treatment of fibrosis.
MX2015011898A (en) Pyrazolo compounds and uses thereof.
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
WO2016066744A3 (en) Gip agonist compounds and methods
MX2016012574A (en) Substituted heteroaryl compounds and methods of use.
WO2016004305A3 (en) Inhibitors of bruton's tyrosine kinase
WO2015015378A3 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
WO2016073771A3 (en) Pyrrolopyrimidine derivatives as mps1/ttk kinase inhibitors
EP3261446A4 (en) Methods and compositions for the treatment or prevention of parkinson's disease
WO2016181220A3 (en) Therapeutic compositions comprising a combination from a curcumin, a harmine and isovanillin component and methods of use thereof
HK1247558A1 (en) Cenicriviroc for the treatment of fibrosis
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
HK1225994A1 (en) Compositions for use in the treatment of allergic conditions
WO2015095789A3 (en) Suppression of allergic lung inflammation and hyperreactivity
WO2016144706A3 (en) Autotaxin inhibitor compounds and uses thereof
WO2016144704A3 (en) Heterocyclic autotaxin inhibitor compounds
HK1230969A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
WO2017210527A8 (en) Autotaxin inhibitors
HK40092382A (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders